|4Sep 30, 2:18 PM ET

NovaBay Pharmaceuticals, Inc. 4

4 · NovaBay Pharmaceuticals, Inc. · Filed Sep 30, 2014

Insider Transaction Report

Form 4
Period: 2014-09-26
Bley Keith R
SVP Product Development
Transactions
  • Award

    Option (right to buy)

    2014-09-26+50,000258,120 total
    Exercise: $0.75From: 2015-09-26Exp: 2024-09-26Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]25% will vest on the first anniversary of the Grant Date. 6.25% will vest every three months thereafter
  • [F2]Options granted pursuant to 2007 Omnibus Incentive Plan

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    BLEY ANNUAL REFRESH GRANT